These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 1533424)

  • 1. Stereoisomeric probes for the D1 dopamine receptor: synthesis and characterization of R-(+) and S-(-) enantiomers of 3-allyl-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine and its 6-bromo analogue.
    Neumeyer JL; Kula NS; Baldessarini RJ; Baindur N
    J Med Chem; 1992 Apr; 35(8):1466-71. PubMed ID: 1533424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (+/-)-3-Allyl-6-bromo-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3- benzazepin, a new high-affinity D1 dopamine receptor ligand: synthesis and structure-activity relationship.
    Neumeyer JL; Baindur N; Niznik HB; Guan HC; Seeman P
    J Med Chem; 1991 Dec; 34(12):3366-71. PubMed ID: 1684995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (+/-)-3-allyl-7-halo-8-hydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines as selective high affinity D1 dopamine receptor antagonists: synthesis and structure-activity relationship.
    Baindur N; Tran M; Niznik HB; Guan HC; Seeman P; Neumeyer JL
    J Med Chem; 1992 Jan; 35(1):67-72. PubMed ID: 1531075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine D1 receptor involvement in the discriminative-stimulus effects of SKF 81297 in squirrel monkeys.
    Rosenzweig-Lipson S; Bergman J
    J Pharmacol Exp Ther; 1993 Nov; 267(2):765-75. PubMed ID: 7902432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Place conditioning with the dopamine D1-like receptor agonist SKF 82958 but not SKF 81297 or SKF 77434.
    Abrahams BS; Rutherford JD; Mallet PE; Beninger RJ
    Eur J Pharmacol; 1998 Feb; 343(2-3):111-8. PubMed ID: 9570457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agonist efficacy and the behavioral effects of dopamine D1 receptor ligands: drug interaction studies in squirrel monkeys.
    Bergman J; Spealman RD; Madras BK; Rosenzweig-Lipson S
    J Pharmacol Exp Ther; 1996 Mar; 276(3):942-50. PubMed ID: 8786574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptor affinities of dopamine D1 receptor-selective novel phenylbenzazepines.
    Neumeyer JL; Kula NS; Bergman J; Baldessarini RJ
    Eur J Pharmacol; 2003 Aug; 474(2-3):137-40. PubMed ID: 12921854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (+/-)-3-[4'-(N,N-dimethylamino)cinnamyl]benzazepine analogs: novel dopamine D1 receptor antagonists.
    Shah JH; Kline RH; Geter-Douglass B; Izenwasser S; Witkin JM; Newman AH
    J Med Chem; 1996 Aug; 39(17):3423-8. PubMed ID: 8765528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catalepsy-associated behavior induced by dopamine D1 receptor antagonists and partial dopamine D1 receptor agonists in squirrel monkeys.
    Rosenzweig-Lipson S; Bergman J
    Eur J Pharmacol; 1994 Aug; 260(2-3):237-41. PubMed ID: 7988649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine D1 and D2 agonist effects on prepulse inhibition and locomotion: comparison of Sprague-Dawley rats to Swiss-Webster, 129X1/SvJ, C57BL/6J, and DBA/2J mice.
    Ralph RJ; Caine SB
    J Pharmacol Exp Ther; 2005 Feb; 312(2):733-41. PubMed ID: 15494551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopaminergic inhibition of catecholamine secretion from chromaffin cells: evidence that inhibition is mediated by D4 and D5 dopamine receptors.
    Dahmer MK; Senogles SE
    J Neurochem; 1996 Jan; 66(1):222-32. PubMed ID: 8522958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential anti-parkinsonian effects of benzazepine D1 dopamine agonists with varying efficacies in the MPTP-treated common marmoset.
    Gnanalingham KK; Erol DD; Hunter AJ; Smith LA; Jenner P; Marsden CD
    Psychopharmacology (Berl); 1995 Feb; 117(3):275-86. PubMed ID: 7770603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the 5-HT1C receptor expressed in Xenopus oocytes by the benzazepines SCH 23390 and SKF 38393.
    Briggs CA; Pollock NJ; Frail DE; Paxson CL; Rakowski RF; Kang CH; Kebabian JW
    Br J Pharmacol; 1991 Dec; 104(4):1038-44. PubMed ID: 1687364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SKF-83959 is not a highly-biased functionally selective D1 dopamine receptor ligand with activity at phospholipase C.
    Lee SM; Kant A; Blake D; Murthy V; Boyd K; Wyrick SJ; Mailman RB
    Neuropharmacology; 2014 Nov; 86():145-54. PubMed ID: 24929112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorescent and biotin probes for dopamine receptors: D1 and D2 receptor affinity and selectivity.
    Madras BK; Canfield DR; Pfaelzer C; Vittimberga FJ; Difiglia M; Aronin N; Bakthavachalam V; Baindur N; Neumeyer JL
    Mol Pharmacol; 1990 Jun; 37(6):833-9. PubMed ID: 2141665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the D1-dopamine agonists SKF-38393 and A-68930 in neonatal 6-hydroxydopamine-lesioned rats: behavioral effects and induction of c-fos-like immunoreactivity.
    Johnson KB; Criswell HE; Jensen KF; Simson PE; Mueller RA; Breese GR
    J Pharmacol Exp Ther; 1992 Aug; 262(2):855-65. PubMed ID: 1354257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The alleged dopamine D1 receptor agonist SKF 83959 is a dopamine D1 receptor antagonist in primate cells and interacts with other receptors.
    Andringa G; Drukarch B; Leysen JE; Cools AR; Stoof JC
    Eur J Pharmacol; 1999 Jan; 364(1):33-41. PubMed ID: 9920182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the enantiomers of SK&F 83566 as specific and stereoselective antagonists at the striatal D-1 dopamine receptor: comparisons with the D-2 enantioselectivity of Ro 22-1319.
    O'Boyle KM; Waddington JL
    Eur J Pharmacol; 1984 Oct; 106(1):219-20. PubMed ID: 6241567
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of dopamine D1 receptors in the lethal effects of cocaine and a quaternary methiodide analog.
    Witkin JM; Newman AH; Nowak G; Katz JL
    J Pharmacol Exp Ther; 1993 Oct; 267(1):266-74. PubMed ID: 7901394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of chronic treatment with selective agonists on the subtypes of dopamine receptors.
    Subramaniam S; Lucki I; McGonigle P
    Brain Res; 1992 Feb; 571(2):313-22. PubMed ID: 1351781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.